Author: David W. W. Dodick, MD, FRCP (C), FACP – Mayo Clinic
### @@@ Peter J. J. Goadsby, MBBS, MD, PhD, DSc, FRACP, FRCP – King’s College London; University of California, Los Angeles ### 1441187###Author###Professor of Neurology###King’s College London; University of California, Los Angeles###Author: Peter J. J. Goadsby, MBBS, MD, PhD, DSc, FRACP, FRCP – King’s College London; University of California, Los Angeles
### @@@ Todd J. Schwedt, MD – Mayo Clinic ### 2099167###Author###Neurologist###Mayo Clinic###Author: Todd J. Schwedt, MD – Mayo Clinic
### @@@ Richard B. B. Lipton, MD – Albert Einstein College of Medicine ### 1764450###Author###Professor and Vice Chair of Neurology, Professor of Epidemiology and Population Health###Albert Einstein College of Medicine###Author: Richard B. B. Lipton, MD – Albert Einstein College of Medicine
### @@@ Chengcheng Liu, PhD – AbbVie ### 2099168###Author###Director, Statistics###AbbVie###Author: Chengcheng Liu, PhD – AbbVie
### @@@ Kaifeng Lu, PhD – AbbVie ### 2099169###Author###Executive Director###AbbVie###Author: Kaifeng Lu, PhD – AbbVie
### @@@ Sung Yun Yu, BA – AbbVie ### 1764465###Author###Scientific Director - Neuroscience Development###AbbVie###Author: Sung Yun Yu, BA – AbbVie
### @@@ Lawrence Severt, MD, PhD – AbbVie ### 2099170###Author###Director###AbbVie###Author: Lawrence Severt, MD, PhD – AbbVie
### @@@ Michelle Finnegan, MS – AbbVie ### 1764466###Author###Executive Director, Neuroscience Development###AbbVie###Author: Michelle Finnegan, MS – AbbVie
### @@@ Joel M. M. Trugman, MD – AbbVie ### 1441172###Author###Associate VP, Clinical Development Neuroscience###AbbVie###Author: Joel M. M. Trugman, MD – AbbVie
###Co-Presenter: Lauren D. Gonser, PharmD, BCPS (she/her/hers) – Kansas City VA Medical Center
### she/her/hers @@@ Brittany Faley, PharmD, BCPS (she/her/hers) – Kansas City VA Medical Center ### 1967858###Co-Presenter###Clinical Pharmacist Practitioner, Pain Management###Kansas City VA Medical Center###Co-Presenter: Brittany Faley, PharmD, BCPS (she/her/hers) – Kansas City VA Medical Center
### she/her/hers PHM-15Co-Presenter: Peter A. Abaci, MD – Boomerang Healthcare
### @@@ Michael F. Sullivan, PT, MSPT (he/him/his) – Integrated Pain Management ### 1967849###Co-Presenter###Physical Therapist###Integrated Pain Management###Co-Presenter: Michael F. Sullivan, PT, MSPT (he/him/his) – Integrated Pain Management
### he/him/his BHV-02.png)
Presenter: Theresa Mallick-Searle, MS, PMGT-BC, ANP-BC – Division Pain Medicine, Stanford Health Care
### @@@ Michael M. Bottros, MD – Keck School of Medicine of USC ### 1052713###Presenter###Clinical Operations and Medical Director for Pain Services, Department of Anesthesiology###Keck School of Medicine of USC###Presenter: Michael M. Bottros, MD – Keck School of Medicine of USC
### PDM-01Author: Karilynn Rockhill, MPH – Rocky Mountain Poison & Drug Safety
### @@@ Hannah Burkett, MS – Rocky Mountain Poison & Drug Safety ### 2099221###Author###Biostatistician I###Rocky Mountain Poison & Drug Safety###Author: Hannah Burkett, MS – Rocky Mountain Poison & Drug Safety
### @@@ Sabrina H Kaplan, MD – Rocky Mountain Poison & Drug Safety ### 2099213###Author###Medical Toxicology Fellow V###Rocky Mountain Poison & Drug Safety###Author: Sabrina H Kaplan, MD – Rocky Mountain Poison & Drug Safety
### @@@ Richard C. Dart, MD, PhD – Rocky Mountain Poison & Drug Safety ### 1441206###Author###Director###Rocky Mountain Poison & Drug Safety###Author: Richard C. Dart, MD, PhD – Rocky Mountain Poison & Drug Safety
### @@@ Joshua C Black, PhD – Rocky Mountain Poison & Drug Safety ### 1089068###Author###Senior Research Scientist###Rocky Mountain Poison & Drug Safety###Author: Joshua C Black, PhD – Rocky Mountain Poison & Drug Safety
###